CAC
NKGNW

Cowen and Company’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Cowen and Company’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-87,717
Closed -$6.2K – 477
2024
Q3 		$6.2K Buy
87,717
+47,917
+120% +$4.28K ﹤0.01% 527
2024
Q2 		$3.46K Buy
39,800
+14,900
+60% +$1.56K ﹤0.01% 543
2024
Q1 		$3.98K Buy
+24,900
New +$2.83K ﹤0.01% 589

Other funds holding NKGNW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return
TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Cowen and Company's NKGNW Position: Q4 2024 in Review

Cowen and Company sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q4 2024, closing a stake of 87,717 shares — an estimated $6.2K sold.

Cowen and Company first reported a position in NKGNW in Q1 2024 and held it in 3 quarters. The position peaked at $6.2K in Q3 2024. 26 funds tracked by Wall St. Rank hold NKGNW as of Q4 2024.

  • Cowen and Company reported no remaining NKGen Biotech, Inc. Warrants position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 87,717 NKGen Biotech, Inc. Warrants shares in Q4 2024, an estimated $6.2K.
  • Cowen and Company first reported a position in NKGen Biotech, Inc. Warrants in Q1 2024 and held it in 3 quarters.
  • Cowen and Company's NKGen Biotech, Inc. Warrants position peaked at $6.2K in Q3 2024.
  • 26 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.